A Phase I/II Trial of Tocilizumab (Anti-IL-6 Receptor) plus Intravenous Immunoglobulin (IVIG) for Desensitization (DES) in Difficult to DES Patients

被引：0
|
作者：
Vo, A. [1 ]
Choi, J. [1 ]
Cisneros, K. [1 ]
Kahwaji, J. [1 ]
Toyoda, M. [2 ]
Bongha, S. [2 ]
Ge, S. [2 ]
Peng, A. [1 ]
Villicana, R. [1 ]
Jordan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Transplant Immunol Lab, Los Angeles, CA 90048 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-00320
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1456
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] A Phase I/II Trial of Tocilizumab (Anti-IL-6 Receptor) plus Intravenous Immunoglobulin (IVIG) for Desensitization (DES) in Difficult to DES Patients
    Vo, A.
    Choi, J.
    Cisneros, K.
    Kahwaji, J.
    Toyoda, M.
    Bongha, S.
    Ge, S.
    Peng, A.
    Villicana, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 103 - 103
  • [2] Tocilizumab (Anti-IL-6 Receptor Antibody) and Intravenous Immunoglobulin (IVIG) in Difficult To Desensitize Patients: Phase I/II Trial
    Vo, Ashley
    Kim, Jua
    Kim, Irene
    Jordan, Stanley
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 49 - 49
  • [3] Extended Analysis of Tocilizumab (anti-IL-6R) + Intravenous Immunoglobulin (IVIG) as Desensitization (DES) Agents for Reduction of Donor Specific Antibodies (DSA) in Patients Resistant to DES With IVIG plus Rituximab
    Vo, A.
    Choi, J.
    Kim, I.
    Kahwaji, J.
    Peng, A.
    Villicana, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [4] A Phase I/II Trial of the Interleukin-6 Receptor Specific Humanized Monoclonal (Tocilizumab) plus Intravenous Immunoglobulin in Difficult to Desensitize Patients
    Vo, Ashley A.
    Choi, Jua
    Kim, Irene
    Louie, Sabrina
    Cisneros, Kristen
    Kahwaji, Joseph
    Toyoda, Mieko
    Ge, Shili
    Haas, Mark
    Puliyanda, Dechu
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    TRANSPLANTATION, 2015, 99 (11) : 2356 - 2363
  • [5] Clinical Efficacy of Anti-IL-6 Receptor Monoclonal Antibody Tocilizumab in Patients with Neuromyelitis Optica
    Araki, Manabu
    Matsuoka, Takako
    Aranami, Toshimasa
    Nakamura, Masakazu
    Okamoto, Tomoko
    Murata, Miho
    Miyake, Sachiko
    Yamamura, Takashi
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 911 - 912
  • [6] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab in three patients with neuromyelitis optica
    Araki, M.
    Aranami, T.
    Matsuoka, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 417 - 417
  • [7] The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
    Shima, Yoshihito
    Kuwahara, Yusuke
    Murota, Hiroyuki
    Kitaba, Shun
    Kawai, Mari
    Hirano, Toru
    Arimitsu, Junsuke
    Narazaki, Masashi
    Hagihara, Keisuke
    Ogata, Atsushi
    Katayama, Ichiro
    Kawase, Ichiro
    Kishimoto, Tadamitsu
    Tanaka, Toshio
    RHEUMATOLOGY, 2010, 49 (12) : 2408 - 2412
  • [8] Extended Experience with Tocilizumab (Anti-IL6R) for Difficult to Desensitize (Des) Patients Awaiting HLA Incompatible Kidney Transplant
    Vo, A.
    Choi, J.
    Kim, I.
    Huang, E.
    Louie, S.
    Kang, A.
    Williamson, S.
    Myers, K.
    Peng, A.
    Najjar, R.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 244 - 245
  • [9] Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients
    Sanchez-Bilbao, Lara
    Martinez-Lopez, David
    Revenga, Marcelino
    Lopez-Vazquez, Angel
    Valls-Pascual, Elia
    Atienza-Mateo, Belen
    Valls-Espinosa, Beatriz
    Maiz-Alonso, Olga
    Blanco, Ana
    Torre-Salaberri, Ignacio
    Rodriguez-Mendez, Veronica
    Garcia-Aparicio, Angel
    Veroz-Gonzalez, Raul
    Jovani, Vega
    Peiteado, Diana
    Sanchez-Orgaz, Margarita
    Tomero, Eva
    De Miera, Francisco J. Toyos-Saenz
    Pinillos, Valvanera
    Aurrecoechea, Elena
    Mora, Angel
    Conesa, Arantxa
    Fernandez-Prada, Manuel
    Troyano, Juan A.
    Calvo-Rio, Vanesa
    Demetrio-Pablo, Rosalia
    Gonzalez-Mazon, Inigo
    Hernandez, Jose L.
    Castaneda, Santos
    Gonzalez-Gay, Miguel A.
    Blanco, Ricardo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 15
  • [10] Potential benefits of the anti-IL-6 receptor antibody tocilizumab in multiple sclerosis patients with high plasmablast frequency
    Araki, M.
    Nakamura, M.
    Sato, W.
    Takahashi, Y.
    Yamamura, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 131 - 131
12345